Unknown OBSERVATIONAL NCT02593435

The Registration Program of BRCA1/2 Gene (RCA)

The Registration Program of BRCA1/2 Gene in Chinese Breast Cancer Group

Sponsor: Chinese Anti-Cancer Association

Interventions NGS test

Updated 10 times since 2017 Last updated: Mar 22, 2016 Started: Oct 31, 2015 Primary completion: Jun 30, 2016 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Breast Cancer, this trial is ongoing. The trial is conducted by Chinese Anti-Cancer Association and has accumulated 10 data snapshots since 2015. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Dec 2021 — Jul 2024 [monthly]

Unknown Status
Jan 2021 — Dec 2021 [monthly]

Unknown Status
Nov 2020 — Jan 2021 [monthly]

Unknown Status

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Unknown Status
May 2018 — Jun 2018 [monthly]

Unknown Status
Apr 2018 — May 2018 [monthly]

Unknown Status

Status: Recruiting → Unknown Status · Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Recruiting NA
Jan 2017 — Aug 2017 [monthly]

Recruiting NA

First recorded

Oct 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Chinese Anti-Cancer Association

Data source: Chinese Anti-Cancer Association

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China